These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


309 related items for PubMed ID: 23663483

  • 1. Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.
    Karnevi E, Said K, Andersson R, Rosendahl AH.
    BMC Cancer; 2013 May 10; 13():235. PubMed ID: 23663483
    [Abstract] [Full Text] [Related]

  • 2. Metformin induces apoptosis of pancreatic cancer cells.
    Wang LW, Li ZS, Zou DW, Jin ZD, Gao J, Xu GM.
    World J Gastroenterol; 2008 Dec 21; 14(47):7192-8. PubMed ID: 19084933
    [Abstract] [Full Text] [Related]

  • 3. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
    Ning J, Clemmons DR.
    Mol Endocrinol; 2010 Jun 21; 24(6):1218-29. PubMed ID: 20363874
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
    Knowlden JM, Gee JM, Barrow D, Robertson JF, Ellis IO, Nicholson RI, Hutcheson IR.
    Breast Cancer Res; 2011 Sep 22; 13(5):R93. PubMed ID: 21939528
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.
    Kisfalvi K, Eibl G, Sinnett-Smith J, Rozengurt E.
    Cancer Res; 2009 Aug 15; 69(16):6539-45. PubMed ID: 19679549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.
    Rozengurt E, Sinnett-Smith J, Kisfalvi K.
    Clin Cancer Res; 2010 May 01; 16(9):2505-11. PubMed ID: 20388847
    [Abstract] [Full Text] [Related]

  • 14. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
    Huang HJ, Angelo LS, Rodon J, Sun M, Kuenkele KP, Parsons HA, Trent JC, Kurzrock R.
    PLoS One; 2011 May 01; 6(10):e26060. PubMed ID: 22022506
    [Abstract] [Full Text] [Related]

  • 15. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells.
    Venieratos PD, Drossopoulou GI, Kapodistria KD, Tsilibary EC, Kitsiou PV.
    Cell Signal; 2010 May 01; 22(5):791-800. PubMed ID: 20067833
    [Abstract] [Full Text] [Related]

  • 16. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J, Sawai H, Matsuo Y, Ochi N, Yasuda A, Takahashi H, Wakasugi T, Funahashi H, Sato M, Takeyama H.
    J Surg Res; 2010 May 01; 160(1):90-101. PubMed ID: 19560785
    [Abstract] [Full Text] [Related]

  • 17. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis.
    Xue J, Zhang H, Liu W, Liu M, Shi M, Wen Z, Li C.
    Reproduction; 2013 Oct 01; 146(4):397-406. PubMed ID: 23904524
    [Abstract] [Full Text] [Related]

  • 18. Action of metformin on the insulin-signaling pathway and on glucose transport in human granulosa cells.
    Rice S, Pellatt LJ, Bryan SJ, Whitehead SA, Mason HD.
    J Clin Endocrinol Metab; 2011 Mar 01; 96(3):E427-35. PubMed ID: 21209036
    [Abstract] [Full Text] [Related]

  • 19. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C, Liu VW, Chan DW, Yao KM, Ngan HY.
    Int J Gynecol Cancer; 2012 Jan 01; 22(1):15-22. PubMed ID: 22080879
    [Abstract] [Full Text] [Related]

  • 20. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
    Winters B, Plymate S, Zeliadt SB, Holt S, Zhang X, Hu E, Lin DW, Morrissey C, Wooldridge B, Gore JL, Porter MP, Wright JL.
    Prostate; 2015 Nov 01; 75(15):1694-703. PubMed ID: 26201966
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.